These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 6690033)

  • 21. Pharmacokinetics of G3139, a phosphorothioate oligodeoxynucleotide antisense to bcl-2, after intravenous administration or continuous subcutaneous infusion to mice.
    Raynaud FI; Orr RM; Goddard PM; Lacey HA; Lancashire H; Judson IR; Beck T; Bryan B; Cotter FE
    J Pharmacol Exp Ther; 1997 Apr; 281(1):420-7. PubMed ID: 9103525
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Distribution, excretion, and metabolism of 3-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-1-(2-chloroethyl)-1-nitrosourea (ACNU) in rats and mice after iv administration.
    Tanaka M; Nishigaki T; Nakajima E; Totsuka S; Nakamura K
    Cancer Treat Rep; 1980; 64(4-5):575-80. PubMed ID: 6933003
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Physiological disposition of 2,2'-anhydro-1-beta-D-arabinofuranosyl-5-fluorocytosine in humans.
    Kreis W; Gordon CS; DeJager R; Krakoff IH
    Cancer Res; 1975 Sep; 35(9):2453-60. PubMed ID: 1149046
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The murine disposition and pharmacokinetics of the antineoplastic agent, diaziquone (NSC 182986).
    Spiegel JF; Egorin MJ; Collins JM; Lerner BD; Bachur NR
    Drug Metab Dispos; 1983; 11(1):41-6. PubMed ID: 6132794
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Formulation and biological distribution of radiolabeled 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea in an animal tumor model.
    Castronovo FP; Potsaid MS; Kopiwoda S
    Cancer Res; 1980 Oct; 40(10):3473-4. PubMed ID: 7438035
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Disposition of the 14C-labeled phosphorothioate oligonucleotide ISIS 2105 after intravenous administration to rats.
    Cossum PA; Sasmor H; Dellinger D; Truong L; Cummins L; Owens SR; Markham PM; Shea JP; Crooke S
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1181-90. PubMed ID: 8166890
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Disposition and metabolism of aniline in Fischer 344 rats and C57BL/6 X C3H F1 mice.
    McCarthy DJ; Waud WR; Struck RF; Hill DL
    Cancer Res; 1985 Jan; 45(1):174-80. PubMed ID: 2578091
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Studies on the tissue-disposition and fate of N-[14C]ethyl-N-nitrosourea in mice.
    Johansson-Brittebo E; Tjälve H
    Toxicology; 1979 Aug; 13(3):275-85. PubMed ID: 230616
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The pharmacokinetics of the antitumor preparation of dimetinur].
    Ostrovskaia LA; Rykova VA; Konradov AA; Ivanov AS; Korman DB
    Eksp Onkol; 1989; 11(2):57-62. PubMed ID: 2737132
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative disposition and whole-body autoradiographic distribution of [2-14C]azidothymidine and [2-14C]thymidine in mice.
    Ahmed AE; Jacob S; Loh JP; Samra SK; Nokta M; Pollard RB
    J Pharmacol Exp Ther; 1991 Apr; 257(1):479-86. PubMed ID: 2020004
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Functional and chemical markers of PCNU activity.
    Kanter PM; Schwartz HS; West CR
    Cancer Drug Deliv; 1983; 1(1):11-20. PubMed ID: 6544115
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biodistribution and metabolism of orally administered mitozolomide in mice.
    Gachon F; Labarre P; Godeneche D; Moreau MF; Papon J; Madelmont JC; Veyre A; Gaillard G
    Drug Metab Dispos; 1993; 21(4):560-6. PubMed ID: 8104113
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The disposition and metabolic fate of 14C-cibenzoline in man.
    Massarella JW; Loh AC; Williams TH; Szuna AJ; Sandor D; Bressler R; Leinweber FJ
    Drug Metab Dispos; 1986; 14(1):59-64. PubMed ID: 2868867
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phase II trial of 1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidyl)-1-nitrosourea in small cell cancer of the lung.
    Chapman RA; Natale RB; Young CW; Wittes RE
    Am J Clin Oncol; 1984 Oct; 7(5):413-4. PubMed ID: 6095639
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Studies in cattle on the disposition of the anti-trypanosomal drug diminazene diaceturate (Berenil).
    Kellner HM; Eckert HG; Volz MH
    Trop Med Parasitol; 1985 Dec; 36(4):199-204. PubMed ID: 4089474
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics, covalent binding and subcellular distribution of [3H]doxorubicin after intravenous administration in the mouse.
    Marafino BJ; Giri SN; Siegel DM
    J Pharmacol Exp Ther; 1981 Jan; 216(1):55-61. PubMed ID: 7452508
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The disposition and pharmacokinetics of alpidem, a new anxiolytic, in the rat.
    Garrigou-Gadenne D; Durand A; Thenot JP; Morselli PL
    Drug Metab Dispos; 1991; 19(3):574-9. PubMed ID: 1680622
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The disposition and metabolism of a hypnotic benzodiazepine, quazepam, in the hamster and mouse.
    Hilbert J; Pramanik B; Symchowicz S; Zampaglione N
    Drug Metab Dispos; 1984; 12(4):452-9. PubMed ID: 6148212
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacology of a new triazine antifolate in mice, rats, dogs, and monkeys.
    Cashmore AR; Skeel RT; Makulu DR; Gralla EJ; Bertino JR
    Cancer Res; 1975 Jan; 35(1):17-22. PubMed ID: 803254
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Disposition of [14C]methyl bromide in rats after inhalation.
    Bond JA; Dutcher JS; Medinsky MA; Henderson RF; Birnbaum LS
    Toxicol Appl Pharmacol; 1985 Apr; 78(2):259-67. PubMed ID: 4035680
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.